Syncom Formulations is trading at INR 22.46, up 5.00%, amid healthcare-sector strength.

  • It extended its advance after gaining 6.58% on September 2 and 12.23% on August 28.
  • No fresh company-specific announcement was identified for September 3; the move appears mainly sector-driven. The BSE Healthcare index was also higher that day, with recent sector gains supported by strong earnings and outlook.
  • The upcoming ₹0.10 dividend and September 30 AGM are known events, not new catalysts.